Mapping the four data gaps between AI drug-discovery models and wet labs
QuanquanGu · x · 2026-11-14
A founder-oriented thread mapping what AI drug-discovery models need from wet labs versus what labs actually deliver.
- Four model groups, four evidence types: understanding cell state needs observations with source and conditions; predicting outcomes needs endpoints and controls that match the prediction; design needs each design linked to whether it was made and whether it worked; experiment selection needs the record of how each choice was made.
- The bottleneck isn't measurement: labs can already measure most of this. The real gaps fall into four buckets — missing measurement, delivery, linkage, and rights — each a different product with a different price.
- For founders: count the unit your model must generalize to. Teams are already commissioning data to their own spec, like Biohub's Billion Cells Project, Recursion's in-house Cell Painting, and Arc Institute's State perturbation model.
More from Venture
- WSJ: Nvidia reportedly weighed billions in guarantees for buyers of its chips — SumitGup · 2026-11-14
- Prescience pitches AI-run health insurance that automates employer benefits — RishabJainK · 2026-11-14
- 'This is Enron 2.0': viral thread claims Nvidia finances its own demand amid $200B of idle GPUs — churchkey · 2026-11-14
- Investor Reveals Dual NBIS-AKAM Position: Betting Both Ends of the Compute Stack — pdamodaran · 2026-11-14
- Bittensor's Gamma would let AI agents pay via buy-and-burn: 100k agents = $365M/yr — bittingthembits · 2026-11-14
- AMD raises guidance: revenue set to grow 80%+ next year as data center AI revenue more than doubles — Beth_Kindig · 2026-11-14